Abstract Details
Sonia Poli
PRESENTER |
No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Patricia Musolino, MD, PhD | Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altas Venture Capital. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. Dr. Musolino has received publishing royalties from a publication relating to health care. |
Marc Martinell | Marc Martinell has received personal compensation for serving as an employee of Minoryx Therapeutics. Marc Martinell has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Minoryx Therapeutics. Marc Martinell has stock in Minoryx Therapeutics. Marc Martinell has received intellectual property interests from a discovery or technology relating to health care. |
Pilar Pizcueta | Pilar Pizcueta has received personal compensation for serving as an employee of Minoryx Therapeutics SL. |